Tag: Serum Institute

India's TB immunisation programme currently offers BCG vaccination at birth or as early as possible till one year of age.

The Drugs Controller General Of India has already approved Covovax for restricted use in emergency situations in adults on December 28.

Serum Institute produces AstraZeneca's Covid-19 vaccine under the brand name Covishield. The vaccine is one of India's two main vaccines against Covid pandemic under mass vaccination drive.

Globally, the supply of vaccines has outmatched the demand and to keep up with the momentum, countries need to join and form some agreement in order to prepare standard rules for clinical trials and manufacturing of the vaccines.

Further, Poonawalla said there was enough data to show that the vaccines will work and protect the children against the infectious disease.

According to the source, the Union government has allowed the commercial export of both vaccines - Covishield and Covaxin - in view of sufficient stock of the vaccines available with the states and Union Territories, and also with the manufacturers.

It was unethical to start giving the third booster dose of Covid vaccine to someone when others in certain countries and populations have not even got two doses for full vaccination, said Adar Poonawalla on Friday

As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center, which developed the Sputnik V jab.

India's Serum Institute is seeking emergency authorisation in the European Union for its Covishield jab, the BBC reported.

The Centre said that more than 30.54 crore vaccine doses have been provided to the states and Union Territories so far. According to the health ministry, 1,50,28,186 Covid doses are still available with the states and Union Territories to be administered.

Novavax Inc had announced that NVX-CoV2373, its recombinant nanoparticle protein-based Covid-19 vaccine, demonstrated 100 per cent protection against moderate and severe disease, 90.4 per cent efficacy overall.

The Drug Controller General of India (DCGI) on Friday granted Serum Institute of India (SII) the permission to manufacture Russian COVID Vaccine- Sputnik V for examination test and analysis at its licensed facility at Hadapsar, ANI quoted sources as saying.

London: Admitting that he is facing immense pressure from “some of the most powerful people in India” demanding supplies of Covishield, Serum Institute of India (SII) CEO Adar Poonawalla said on…

New Delhi: Serum Institute of India (SII) — the maker of the most used COVID-19 vaccine in the country — on Wednesday announced a cut in price of the jab…

Bhubaneswar: Odisha Chief Minister Naveen Patnaik talked to Adar Poonawalla, CEO of Serum Institute over a video call today to discuss on progress of Covid vaccine. The Chief Minister expressed happiness that Serum Institute has partnered with Oxford University to develop Covid vaccine and sought his cooperation to begin early vaccination in Odisha once necessary […]